IIM
MBX

INTECH Investment Management’s MBX Biosciences MBX Stock Holding History

INTECH Investment Management’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$204K Sell
6,844
-14
-0.2% -$476 ﹤0.01% 1744
2025
Q4 		$216K Buy
+6,858
New +$166K ﹤0.01% 1942
2025
Q3 		– Sell
-14,271
Closed -$163K – 2539
2025
Q2 		$163K Buy
14,271
+3,543
+33% +$36.1K ﹤0.01% 2156
2025
Q1 		$79.2K Buy
+10,728
New +$113K ﹤0.01% 2367

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

INTECH Investment Management's MBX Position: Q1 2026 in Review

INTECH Investment Management reduced its MBX Biosciences (MBX) stake by 0.2% in Q1 2026, selling an estimated $476 and leaving 6,844 shares worth $204K. The position accounts for ﹤0.01% of the portfolio, ranked #1744.

INTECH Investment Management first reported a position in MBX in Q1 2025 and has held it in 4 quarters since. The position peaked at $216K in Q4 2025. 157 funds tracked by Wall St. Rank hold MBX as of Q1 2026.

  • INTECH Investment Management held 6,844 shares of MBX Biosciences worth $204K as of Q1 2026.
  • INTECH Investment Management sold 14 MBX Biosciences shares in Q1 2026, an estimated $476.
  • MBX Biosciences made up ﹤0.01% of INTECH Investment Management's portfolio in Q1 2026, its #1744 holding.
  • INTECH Investment Management first reported a position in MBX Biosciences in Q1 2025 and has held it in 4 quarters since.
  • INTECH Investment Management's MBX Biosciences position peaked at $216K in Q4 2025.
  • 157 funds tracked by Wall St. Rank held MBX Biosciences as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.